BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 38435791)

  • 21. Cardiomyocyte Maturation: New Phase in Development.
    Guo Y; Pu WT
    Circ Res; 2020 Apr; 126(8):1086-1106. PubMed ID: 32271675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.
    Karbassi E; Fenix A; Marchiano S; Muraoka N; Nakamura K; Yang X; Murry CE
    Nat Rev Cardiol; 2020 Jun; 17(6):341-359. PubMed ID: 32015528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-efficiency RNA-based reprogramming of human primary fibroblasts.
    Kogut I; McCarthy SM; Pavlova M; Astling DP; Chen X; Jakimenko A; Jones KL; Getahun A; Cambier JC; Pasmooij AMG; Jonkman MF; Roop DR; Bilousova G
    Nat Commun; 2018 Feb; 9(1):745. PubMed ID: 29467427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rodent models in Down syndrome research: impact and future opportunities.
    Herault Y; Delabar JM; Fisher EMC; Tybulewicz VLJ; Yu E; Brault V
    Dis Model Mech; 2017 Oct; 10(10):1165-1186. PubMed ID: 28993310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases.
    Pelleri MC; Gennari E; Locatelli C; Piovesan A; Caracausi M; Antonaros F; Rocca A; Donati CM; Conti L; Strippoli P; Seri M; Vitale L; Cocchi G
    Genomics; 2017 Oct; 109(5-6):391-400. PubMed ID: 28648597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
    M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
    Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes.
    Karakikes I; Ameen M; Termglinchan V; Wu JC
    Circ Res; 2015 Jun; 117(1):80-8. PubMed ID: 26089365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemically defined generation of human cardiomyocytes.
    Burridge PW; Matsa E; Shukla P; Lin ZC; Churko JM; Ebert AD; Lan F; Diecke S; Huber B; Mordwinkin NM; Plews JR; Abilez OJ; Cui B; Gold JD; Wu JC
    Nat Methods; 2014 Aug; 11(8):855-60. PubMed ID: 24930130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased cell proliferation and higher oxidative stress in fibroblasts from Down Syndrome fetuses. Preliminary study.
    Gimeno A; García-Giménez JL; Audí L; Toran N; Andaluz P; Dasí F; Viña J; Pallardó FV
    Biochim Biophys Acta; 2014 Jan; 1842(1):116-25. PubMed ID: 24184606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagen VI regulates satellite cell self-renewal and muscle regeneration.
    Urciuolo A; Quarta M; Morbidoni V; Gattazzo F; Molon S; Grumati P; Montemurro F; Tedesco FS; Blaauw B; Cossu G; Vozzi G; Rando TA; Bonaldo P
    Nat Commun; 2013; 4():1964. PubMed ID: 23743995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human embryonic stem cell-derived cardiomyocytes migrate in response to gradients of fibronectin and Wnt5a.
    Moyes KW; Sip CG; Obenza W; Yang E; Horst C; Welikson RE; Hauschka SD; Folch A; Laflamme MA
    Stem Cells Dev; 2013 Aug; 22(16):2315-25. PubMed ID: 23517131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the pathobiology of Down syndrome--hyaluronan synthase-2 overexpression is regulated by collagen VI α2 chain.
    Karousou E; Stachtea X; Moretto P; Viola M; Vigetti D; D'Angelo ML; Raio L; Ghezzi F; Pallotti F; De Luca G; Karamanos NK; Passi A
    FEBS J; 2013 May; 280(10):2418-30. PubMed ID: 23452080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue mechanics and fibrosis.
    Wells RG
    Biochim Biophys Acta; 2013 Jul; 1832(7):884-90. PubMed ID: 23434892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partitioning the heart: mechanisms of cardiac septation and valve development.
    Lin CJ; Lin CY; Chen CH; Zhou B; Chang CP
    Development; 2012 Sep; 139(18):3277-99. PubMed ID: 22912411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular matrix and heart development.
    Lockhart M; Wirrig E; Phelps A; Wessels A
    Birth Defects Res A Clin Mol Teratol; 2011 Jun; 91(6):535-50. PubMed ID: 21618406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysfunctional tendon collagen fibrillogenesis in collagen VI null mice.
    Izu Y; Ansorge HL; Zhang G; Soslowsky LJ; Bonaldo P; Chu ML; Birk DE
    Matrix Biol; 2011 Jan; 30(1):53-61. PubMed ID: 20951202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cardiac cushion development by hyaluronan.
    Camenisch TD; Biesterfeldt J; Brehm-Gibson T; Bradley J; McDonald JA
    Exp Clin Cardiol; 2001; 6(1):4-10. PubMed ID: 20428437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix.
    Delom F; Burt E; Hoischen A; Veltman J; Groet J; Cotter FE; Nizetic D
    Proteome Sci; 2009 Aug; 7():31. PubMed ID: 19715584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of extracellular matrix to the mechanical properties of the heart.
    Fomovsky GM; Thomopoulos S; Holmes JW
    J Mol Cell Cardiol; 2010 Mar; 48(3):490-6. PubMed ID: 19686759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project.
    Freeman SB; Bean LH; Allen EG; Tinker SW; Locke AE; Druschel C; Hobbs CA; Romitti PA; Royle MH; Torfs CP; Dooley KJ; Sherman SL
    Genet Med; 2008 Mar; 10(3):173-80. PubMed ID: 18344706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.